Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

Journal of Pathology

Volumn 194, Issue 3, 2001, Pages 349-357

  Nocito, Antonio ^g   Bubendorf, Lukas ^g   Tinner, Eva Maria ^a   Süess, Katrin ^a   Wagner, Urs ^a   Forster, Thomas ^a   Kononen, Juha ^b   Fijan, André ^a   Bruderer, James ^a   Schmid, Ulrico ^c   Ackermann, Daniel ^c   Maurer, Robert ^d   Alund, Göran ^d   Knönagel, Hartmut ^e   Rist, Marcus ^f   Anabitarte, Manuel ^g   Hering, Franz ^g   Hardmeier, Thomas ^h   Schoenenberger, Andreas J ^h   Flury, Renata ⁱ   Jäger, Peter ⁱ   Fehr, Jean Luc ^j   Schraml, Peter ^a   Moch, Holger ^a   Mihatsch, Michael J ^a   Gasser, Thomas ^a   Sauter, Guido ^a   more..

^a UNIVERSITY OF BASEL   (Switzerland)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^d TRIEMLI HOSPITAL   (Switzerland)

^e Limmattal Hospital   (Switzerland)

^f Clara Hospital   (Switzerland)

^g Kantonsspital Baden   (Switzerland)

^h Kantonsspital Muensterlingen   (Switzerland)

ⁱ CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^j Cantonal Hospital Schaffhausen ^*  (Switzerland)

more..

Author keywords

Bladder cancer; Grade; Ki67 LI; Prognosis; Tissue microarrays; TMA

Indexed keywords

GLASS; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION FUNCTION; DNA MICROARRAY; DONOR; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; SAMPLE; TISSUE SECTION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 0034942973     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D     Document Type: Article

References (26)

1. Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma
2. Use of a cDNA microarray to analyse gene expression patterns in human cancer
3. Tissue microarrays for high-throughput molecular profiling of hundreds of specimens
4. Histological Typing of Urinary Bladder Tumors
5. Clinical significance of interobserver differences in staging and grading of superficial bladder cancer
6. Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder
7. The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial
8. p53 but not erbB-2 expression is associated with rapid tumor cell proliferation in urinary bladder cancer
9. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer
10. Nonparametric estimation from incomplete observations
11. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder
12. Proliferative activity of urothelial neoplasms: Comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions
13. Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer
14. Progression and survival in transitional cell bladder cancer: A comparison of established factors, S-phase fraction and DNA ploidy
15. Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining
16. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?
17. Grading of superficial bladder cancer by quantitative mitotic frequency analysis
18. The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma
19. Rationalisation of follow-up in patients with non-invasive bladder tumours. A preliminary report
20. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations
21. Analysis of performance of pathologists in the grading of bladder tumors
22. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays
23. High-throughput tissue microarray analysis to evaluate the significance of genes uncovered by cDNA microarray screening in renal cell carcinoma
24. Molecular mechanisms of hormone therapy failure in human prostate cancer analyzed by a combination of cDNA and tissue microarrays
25. Tissue microarrays for gene amplification surveys in many different tumor types